The biggest acquisition in Google’s history just cleared its final major hurdle. Alphabet (GOOGL) has received unconditional EU antitrust approval for its $32 billion acquisition of cybersecurity firm Wiz. In a rare swift decision for Big Tech M&A, regulators concluded that the deal does not harm competition, effectively giving Google a pass to bolster its...
The global smart money is doubling down on the Indian homeowner. The Carlyle Group (CG) announced a ₹21 billion ($232 million) strategic investment in Nido Home Finance (the housing finance arm of Edelweiss Financial). The deal structure is aggressive, moving Carlyle from a simple investor to the dominant owner. 🏠 THE DEAL STRUCTURE: 🔄 THE...
Masayoshi Son has found his new WeWork—but this time, the stakes are $30 billion higher. SoftBank Group (9984.T) is expected to report a healthy profit on Thursday, driven by paper gains on its massive investment in OpenAI. However, investor sentiment is souring as the market pivots from celebrating the valuation to scrutinizing the cost of...
The Indian retail investor just blinked. In a stunning reversal of post-pandemic trends, inflows into Indian Gold ETFs surpassed net inflows into Equity Mutual Funds in January 2026. Data from the Association of Mutual Funds in India (AMFI) shows that while equity flows dipped, gold demand exploded as investors sought safety from geopolitical chaos. 📊...
The “Alternative” label is becoming obsolete. Apollo is now a mainstream credit utility. Apollo Global Management (APO) reported a blowout fourth quarter on Monday, delivering a 13% rise in profit that handily beat Wall Street expectations. Adjusted net income hit $1.54 billion ($2.47/share vs. $2.05 est.), driven by a massive surge in debt origination and...
The world’s most valuable pharma company is using its weight loss windfall to fund the next generation of genetic medicine. Eli Lilly (LLY) announced Monday it has agreed to acquire Orna Therapeutics for up to $2.4 billion in cash. While Lilly dominates the metabolic market (Mounjaro/Zepbound), this deal signals a massive pivot into Immunology and...